Skip to content

The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …

As I reported in this week's issue of Inside Stanford Medicine, Scott Metzler, PhD, is a researcher who not only studies the early development of …

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.